SCHEMBL22065152

SCHEMBL22065152

N#Cc1ccc(-c2ccc(-c3c(-c4ccc5ccc(-c6ccc(-c7nc(-c8ccccc8)nc(-c8ccccc8)n7)cc6)cc5c4)ccc4ccccc34)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 11/20 0.42
▸ ABCB1 P08183 5/20 0.42
▸ SLC22A12 Q96S37 1/20 0.41
▸ ADORA2A P29274 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ ABCC1 P33527 2/20 0.39
▸ PDPK1 O15530 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22114987 0.96 ABCG2 (0.43) ABCG2ABCB1SLC22A12ADORA2AADORA1
SCHEMBL21131500 0.94 ABCG2 (0.43) ABCG2ABCB1SLC22A12ADORA2ACA1
SCHEMBL22065328 0.93 CYP1A2 (0.46) ABCG2ADORA2AADORA1MEN1ALDH1A1
SCHEMBL19942063 0.91 ABCG2 (0.46) ABCG2ABCB1SLC22A12CA1CA2
SCHEMBL19942058 0.91 ABCG2 (0.46) ABCG2ABCB1SLC22A12CA1CA2
SCHEMBL22064717 0.91 ABCG2 (0.46) ABCG2ABCB1SLC22A12CA1CA2
SCHEMBL21658471 0.90 CYP11B1 (0.45) ABCG2ABCB1SLC22A12ADORA2AADORA1
SCHEMBL21131849 0.90 ABCG2 (0.44) ABCG2ABCB1SLC22A12ADORA2ACA1
SCHEMBL21658388 0.90 ABCG2 (0.47) ABCG2ABCB1SLC22A12CA1CA2
SCHEMBL19942057 0.90 ABCG2 (0.47) ABCG2ABCB1SLC22A12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181096-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181096-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, AHR ABCG2 2815/4885ABCB1 2655/4885SLC22A12 4126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback